SCHEMBL8910230

SCHEMBL8910230

CCOC(=O)C1=C(C)c2c(C)c3c(cc2=N1)-c1cc(C#N)ccc1N=3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
ELANE P08246 1/20 0.35
SETD7 Q8WTS6 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HRH2 P25021 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8909629 0.85 CA12 (0.39) GABRG2GABRB3GABRA5SMN1; SMN2KDM4E
SCHEMBL8909809 0.84 TSHR (0.37) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL9434374 0.84 SMAD3 (0.39) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL8912086 0.83 CYP2C9 (0.39) TSHRNPSR1KDM4EALDH1A1HPGD
SCHEMBL8911562 0.83 POLB (0.40) GABRG2GABRB3GABRA5MAPK1NPSR1
SCHEMBL1388815 0.83 MAPT (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL1388445 0.75 CA12 (0.37) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL8909720 0.73 DHODH (0.38) NPSR1KDM4EALDH1A1HPGDMAPT
SCHEMBL9434967 0.72 MAPT (0.42) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL8156114 0.71 CHRM2 (0.38) KDM4EALDH1A1HSD17B10MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed